Business profile
Loading canonical business information.
About
No public description is available.
Services
Products
Offers
Published by the business. Confirm current availability and terms with the business.
Promotions
Published by the business. Confirm current availability and terms with the business.
Frequently asked questions
Answers published by the business.
Published agent capabilities
Capabilities recorded in this listing. Their presence is not a live availability check.
AI-readable discovery
Read the structured business information and inspect the published discovery documents.
Machine-readable documents do not by themselves establish a live AI agent, checkout or business ownership.
Request a quote
Loading quote availability…
Sources
Report this listing
Tell us what needs reviewing. Removal requests are reviewed before any change is made.
Request removalProfile information
Publication, owner access and business registry verification are separate. Verification badges describe the checks completed; public references identify this listing.
Structured public business summary
Kompetenznetz Multiple Sklerose
Kompetenznetz Multiple Sklerose - Zum Inhalt springen Suchen LOGIN en de Spenden Kontakt News Tools Qualitätshandbuch MS, NMOSD, MOGAD Patientenhandbuch MS, NMOSD Qualitätshandbuch Myasthene Syndrome EDSS-Rechner Kitteltaschenfächer Merkzettel für Patienten Patientenaufklärungen Workflowtabellen Positionspapiere Forschung Kohortenstudien FaBIO Publikationen Patienteninformation Impfung und MS Publikationen Kooperationen Fortbildung Nachwuchsförderung MS Specialist MS Studiengang Über uns Verein Personen Studienzentren Task Forces Externe Datenbanken Online-Spende Kontakt Patienteninformation Patienteninformation Multiple Sklerose verstehen, beobachten und therapieren. MS Specialist – Fortbildungen Aktuelle Fortbildungsveranstaltungen für Zertifizierung und Rezertifizierung News 22.07.2026 EU-Zulassung von Cenrifki® (Tolebrutinib) für nrSPMS Stellungnahme des KKNMS 15.06.2026 MSTKG Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose Update 2026 13.05.2026 Zeitverlust kann irreversible neurologische Schäden bedeuten Verzögerungen bei der Kostenerstattung leitliniengerechter MS-Therapien in der PKV 19.01.2026 Wichtige Aktualisierung der Impfstrategie bei Multipler Sklerose vor und bei Immuntherapie Empfehlungen des KKNMS e.V. 19.12.2025 Stellungnahme zu Missständen in der aktuellen ASV-Multiple Sklerose Task Force Versorgungsstrukturen und Therapeutika des KKNMS e.V.
Germany
Business nature
- Primary business nature
- Not provided
- Customer market
- Not provided
Operating hours
Hours not provided.
Categories
- Other Businesses & Services (primary)
Service areas
- Germany
Public contacts
- Public email: info@kkn-ms.de
- Public phone: 22.07.2026
- kompetenznetz-multiplesklerose: https://www.kompetenznetz-multiplesklerose.de/
- linkedin: https://www.linkedin.com/company/kknms-e-v
Declared AI capabilities
- Online booking — Detected from public website navigation or discovery metadata.
- Online support — Detected from public website navigation or discovery metadata.
Directory status
Registry verification: Not Registry Verified
Directory score: 85
Public source evidence
- Kompetenznetz Multiple Sklerose -
- Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration - Kompetenznetz Multiple Sklerose
- Serviceangebot für Neurologen erweitert - Kompetenznetz Multiple Sklerose
- About us - Kompetenznetz Multiple Sklerose
- Über uns - Kompetenznetz Multiple Sklerose
- KKNMS Tools - Kompetenznetz Multiple Sklerose
- Kompetenznetz Multiple Sklerose -
- KKNMS Tools - Kompetenznetz Multiple Sklerose
- Pressemitteilungen / News - Kompetenznetz Multiple Sklerose
- Kompetenznetz Multiple Sklerose -